Jiang Wenbin bought CTKB
May 20, 2024 · Form 4 insider transaction
Jiang Wenbin bought 7,854 shares of Cytek Biosciences, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,854
Price
N/A
Total value
N/A
InsiderJiang Wenbin
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 20, 2024
Filing dateMay 22, 2024
Shares owned after5,316,922
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.